Skip to main content
. 2020 Jul 1;13:1611–1619. doi: 10.2147/JPR.S256205

Table 1.

Qualitative Evaluation of the Studies That Assessed the Postoperative Analgesia of ESPB on Lumbar Spine Surgery

Author Country Study Design Study Size Surgical Operation ESPB Outcome Side Effect Follow-Up Time Conclusion
Canturk et al (2019)15 Turkey Case report 1 Lumbar spinal fusion L1 vertebra level, both sides with 10 mL bupivacaine 0.25% and 10 mL prilocaine 1%, single-shot. Opioid consumption, NRS pain scores. None 24 hours ESPB provides a clear surgical field and long-lasting postoperative analgesia.
De et al (2019)16 Spain Case series 8 Lumbar spinal fusion L4 vertebra level, both sides with 20 mL ropivacaine 0.2%, single-shot. VAS pain scores, rescue analgesia consumption. None 48 hours Lumbar ESP appears to contribute to pain control during the first 48 hours after lumbar spinal fusion.
Singh et al (2019)17 India Case series 7 Surgery for PLID or lumbar stenosis T10 vertebra level, both sides with 20 mL bupivacaine 0.25%, single-shot. NRS score, rescue analgesia. None 10 hours The average length of analgesia provided by ESPB was between 6 and 8 hours.
Almeida et al (2019)18 Portugal Case report 1 L2–S1 spine fusion Post-operative day 1, T8 vertebra level, both sides with 20mL ropivacaine 0.2%, ESP catheterizations and continuous infusion (5 mL/hour) of ropivacaine 0.2% per side was maintained for 48 hours. NRS scores None 48 hours Bilateral ESP catheterizations at T8 are safe and contribute to significant analgesic improvement.
Singh et al (2019)19 India RCT 40 Elective lumbar spine surgery T10 vertebra level, both sides with 20 mL bupivacaine 0.5%, single-shot. Opioid consumption, NRS scores, patient satisfaction. Two patients in the control group developed severe nausea and vomiting. 24 hours US-guided ESP block reduces postoperative opioid requirement and improves patient satisfaction.
Ueshima et al (2019)20 Japan Retrospective study 41 Lumbar spinal surgery Target vertebral level, both sides with 20 mL levobupivacaine 0.375%. NRS scores, analgesia consumption, complications. None 24 hours The ESP block provides effective postoperative analgesic effect for 24 hours.
Yayik et al (2019)21 Turkey RCT 60 Open lumbar decompression L3 vertebra level, both sides with 20 mL bupivacaine 0.25%, single-shot. VAS scores, opioid consumption, rescue analgesia, opioid-related side effects. None 24 hours ESP block can be used in multimodal analgesia practice to reduce opioid consumption and relieve acute postoperative pain.
Brandao et al (2018)22 Portugal Clinical report 1 Lumbar spine surgery L4 vertebra level, both sides with 15 mL ropivacaine 0.375%, single-shot. Pain scores, analgesia consumption. None 48 hours Performing the block preoperatively dismissed the need for extra intraoperative opioids other than those for intubation and provide a clear surgical field.
Calandese et al (2018)23 Italy Case report 1 Anterior thoracolumbar spine surgery T10 vertebra level, a total of 40 mL of 0.25% levobupivacaine and 2 mL (8 mg) of dexamethasone was injected bilaterally. NRS scores, analgesia consumption. None 24 hours ESPB as part of a multimodal analgesia strategy can provide effective postoperative pain management after anterior thoracolumbar spine surgery.
Cesur et al (2018)24 Turkey Case series 5 Lumbar surgery T12 vertebra level, both sides with 20 mL local anesthetic solution containing bupivacaine 0.25% and lidocaine 1%, single-shot. NRS scores, analgesia consumption. None 24 hours ESPB achieved effective analgesia and reduced opioid consumption in the single or multilevel lumbar spine surgeries.
Melvin et al (2018)11 USA Case series 6 Lumbosacral spine surgery T10 (n= 2) and T12 (n= 4), which concluded 3 single-injection and 3 continuous ESPB. NRS scores, analgesia use. None 72 hours The ESP block contribute significantly to analgesia and enhance recovery.

Abbreviations: ESPB, erector spinae plane block; ESP, erector spinae plane; NRS, numeric rating scales; VAS, visual analogue scales; PLID, prolapsed lumbar intervertebral disk; RCT, randomized controlled trial; US, ultrsound.